Timothy Herpin,

VP, Janssen Business Development, Infectious Diseases and Vaccines

Tim leads the strategy and planning of all business development activities in support of Janssen’s Infectious Diseases and Vaccines therapeutic area. This includes transactions, acquisitions, scientific licensing and alliance management. Tim is based in South San Francisco.

Before joining Johnson & Johnson, Tim spent more than 15 years in Business Development roles in biotech and pharmaceutical companies. He was the Chief Business Officer at Caribou Biosciences, a privately held gene editing company based in the Bay Area. Prior to that, Tim was Vice-President, Head of Transactions at AstraZeneca and led a group of business development professionals involved in all aspects of transaction negotiation and execution. Tim joined AstraZeneca in 2011 as Vice-President, Strategic Partnering and Business Development, covering all business development activities for the Neuroscience disease area and subsequently for the Oncology disease area. Prior to AstraZeneca, Tim spent eight years in the business development organization at Bristol-Myers Squibb covering both search and evaluation as well as transaction in multiple disease areas. Before his business development career, Tim worked in R&D at Bristol-Myers Squibb, Aventis and Pharmacopeia.

Tim is a graduate of Ecole Polytechnique in France. He also holds a Ph.D. in organic chemistry from University College London and an MBA in Finance from NYU Stern.

Timothy Herpin
Timothy Herpin